Seqens Revenue and Competitors
Estimated Revenue & Valuation
- Seqens's estimated annual revenue is currently $272M per year.
- Seqens's estimated revenue per employee is $208,786
Employee Data
- Seqens has 1303 Employees.
- Seqens grew their employee count by 3% last year.
Seqens's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO Wavelength Pharmaceuticals Ltd., General Manager SEQENS Israel | Reveal Email/Phone |
3 | PA To CEO & President | Reveal Email/Phone |
4 | Chief Staff - R&D | Reveal Email/Phone |
5 | Head Innovation – Pipeline feeding, Process and IP | Reveal Email/Phone |
6 | Head Group Biotechnology R&D | Reveal Email/Phone |
7 | Head Manufacturing and Supply | Reveal Email/Phone |
8 | Head GMP testing | Reveal Email/Phone |
9 | Head Innovative Chemical Development | Reveal Email/Phone |
10 | Head Quality Control | Reveal Email/Phone |
Seqens Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $14.1M | 583 | 534% | N/A | N/A |
#2 | $1.6M | 53 | 212% | N/A | N/A |
#3 | $212.8M | 1063 | 5% | $65M | N/A |
#4 | $6.8M | 65 | 27% | $68.2M | N/A |
#5 | $12.9M | 92 | 2% | $23.1M | N/A |
#6 | $1M | 12 | N/A | N/A | N/A |
#7 | $106.5M | 469 | -3% | $206M | N/A |
#8 | $35.6M | 247 | 18% | N/A | N/A |
#9 | $38.3M | 277 | 23% | N/A | N/A |
#10 | $45M | 299 | -4% | $102.6M | N/A |
What Is Seqens?
SEQENS is an integrated global leader in pharmaceutical synthesis and specialty ingredients, delivering unrivalled market responsiveness and tailor-made solutions to our customers. SEQENS operates 24 manufacturing plants and 3 R&D centers in Europe, North America and Asia with 3,200 employees. More than 300 scientists, engineers and experts develop tailor-made solutions for our customers and ensure that products are successfully transferred into production.
keywords:N/A
N/A
Total Funding
1303
Number of Employees
$272M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Seqens News
Symrise, BASF, Ashland, DSM, Seqens, Salicylates and Chemicals, Croda International, Sunjin Beauty Science, Sensient Technologies,...
Global Methyl Silicate Market 2022 Industry Growth Seqens, Drägerwerk AG and Co. KGaA, WACKER, Wilshire Technologies · North America (United...
Increases R&D capability and productivity in the U.S. and builds on merger with CDMO Wavelength Pharmaceuticals. 03.21.22. SEQENS, a manufacturer of active...